These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15096567)

  • 1. Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types.
    Flores-Munguia R; Siegel E; Klimecki WT; Giuliano AR
    J Mol Diagn; 2004 May; 6(2):115-24. PubMed ID: 15096567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer.
    Moberg M; Gustavsson I; Gyllensten U
    J Clin Microbiol; 2003 Jul; 41(7):3221-8. PubMed ID: 12843067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis.
    Lai HC; Peng MY; Nieh S; Yu CP; Chang CC; Lin YW; Sun CA; Chu TY
    Int J Gynecol Cancer; 2006; 16(2):730-5. PubMed ID: 16681753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of HPV types before and after treatment of cervical intraepithelial neoplasia grade 2 and 3.
    Lindroth Y; Bjelkenkrantz K; Forslund O
    J Clin Virol; 2017 Dec; 97():38-43. PubMed ID: 29100063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.
    Kraus I; Molden T; Holm R; Lie AK; Karlsen F; Kristensen GB; Skomedal H
    J Clin Microbiol; 2006 Apr; 44(4):1310-7. PubMed ID: 16597856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in type-specific human papillomavirus load predict progression to cervical cancer.
    Depuydt CE; Criel AM; Benoy IH; Arbyn M; Vereecken AJ; Bogers JJ
    J Cell Mol Med; 2012 Dec; 16(12):3096-104. PubMed ID: 22978795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.
    Sandri MT; Lentati P; Benini E; Dell'Orto P; Zorzino L; Carozzi FM; Maisonneuve P; Passerini R; Salvatici M; Casadio C; Boveri S; Sideri M
    J Clin Microbiol; 2006 Jun; 44(6):2141-6. PubMed ID: 16757611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
    Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
    J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population.
    Baasland I; Romundstad PR; Eide ML; Jonassen CM
    PLoS One; 2019; 14(1):e0210997. PubMed ID: 30673759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation.
    Gravitt PE; Burk RD; Lorincz A; Herrero R; Hildesheim A; Sherman ME; Bratti MC; Rodriguez AC; Helzlsouer KJ; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):477-84. PubMed ID: 12814990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining detection threshold and improving analytical proficiency of HPV testing in clinical specimens.
    Chao FY; Chao A; Huang CC; Hsueh S; Yang JE; Huang HJ; Wang LC; Lin CT; Chou HH; Lai CH
    Gynecol Oncol; 2010 May; 117(2):302-7. PubMed ID: 20206982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays.
    Roberts CC; Tadesse AS; Sands J; Halvorsen T; Schofield TL; Dalen A; Skjeldestad FE; Jansen KU
    J Clin Virol; 2006 Aug; 36(4):277-82. PubMed ID: 16765639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
    Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay.
    Wong AK; Chan RC; Nichols WS; Bose S
    J Clin Microbiol; 2008 Mar; 46(3):869-75. PubMed ID: 18174309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion.
    Molden T; Kraus I; Karlsen F; Skomedal H; Nygård JF; Hagmar B
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):367-72. PubMed ID: 15734959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High level of correlation of human papillomavirus-16 DNA viral load estimates generated by three real-time PCR assays applied on genital specimens.
    Fontaine J; Gravitt P; Duh LM; Lefevre J; Pourreaux K; Hankins C; Coutlée F
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2200-7. PubMed ID: 16172232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
    Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
    J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.
    Xi LF; Schiffman M; Hughes JP; Galloway DA; Koutsky LA; Kiviat NB
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1388-1394. PubMed ID: 31101617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.